Novavax Licenses Matrix-M Adjuvant to Pfizer in $530M Deal
Novavax, Inc. (NASDAQ: NVAX) entered into a license agreement with Pfizer Inc. for non‑exclusive rights to...
NASDAQ: NVAX
Sanofi Receives FDA Fast-Track Designation for Influenza and COVID-19 Combo Vaccine Candidates
Sanofi (NASDAQ: SNY) has announced that it has received Fast-Track Designations from the US Food...
Novavax to Sell Czech Manufacturing Facility to Novo Nordisk for $200 Million
US-based Novavax, Inc. (NASDAQ: NVAX) has reached an agreement to sell its manufacturing facility located...